144 related articles for article (PubMed ID: 8630410)
1. Activation-dependent alpha5beta1 integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells.
Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
Blood; 1996 Mar; 87(6):2450-8. PubMed ID: 8630410
[TBL] [Abstract][Full Text] [Related]
2. Activation of beta1 integrins on CML progenitors reveals cooperation between beta1 integrins and CD44 in the regulation of adhesion and proliferation.
Lundell BI; McCarthy JB; Kovach NL; Verfaillie CM
Leukemia; 1997 Jun; 11(6):822-9. PubMed ID: 9177435
[TBL] [Abstract][Full Text] [Related]
3. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
Bhatia R; Munthe HA; Verfaillie CM
Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores beta1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.
Bhatia R; Verfaillie CM
Blood; 1998 May; 91(9):3414-22. PubMed ID: 9558400
[TBL] [Abstract][Full Text] [Related]
5. Integrin-mediated regulation of hematopoiesis: do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
Verfaillie CM; Hurley R; Lundell BI; Zhao C; Bhatia R
Acta Haematol; 1997; 97(1-2):40-52. PubMed ID: 8980609
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV.
Verfaillie CM; McCarthy JB; McGlave PB
J Clin Invest; 1992 Oct; 90(4):1232-41. PubMed ID: 1383271
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells.
Moore S; Haylock DN; Lévesque JP; McDiarmid LA; Samels LM; To LB; Simmons PJ; Hughes TP
Blood; 1998 Oct; 92(7):2461-70. PubMed ID: 9746786
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia.
Bhatia R; McCarthy JB; Verfaillie CM
Blood; 1996 May; 87(9):3883-91. PubMed ID: 8611716
[TBL] [Abstract][Full Text] [Related]
9. Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors.
Bhatia R; Munthe HA; Verfaillie CM
Exp Hematol; 1999 Sep; 27(9):1384-96. PubMed ID: 10480429
[TBL] [Abstract][Full Text] [Related]
10. Abnormal growth factor modulation of beta1-integrin-mediated adhesion in chronic myelogenous leukaemia haematopoietic progenitors.
Bhatia R; Munthe HA; Forman SJ
Br J Haematol; 2001 Dec; 115(4):845-53. PubMed ID: 11843818
[TBL] [Abstract][Full Text] [Related]
11. Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors.
Bhatia R; Williams AD; Munthe HA
Exp Hematol; 2002 Apr; 30(4):324-32. PubMed ID: 11937267
[TBL] [Abstract][Full Text] [Related]
12. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor and chronic myeloid leukemia CD34+ cells.
Moore S; McDiarmid LA; Hughes TP
Leuk Lymphoma; 2000 Jul; 38(3-4):211-20. PubMed ID: 10830729
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha and bcr-abl antisense oligodeoxynucleotides in combination enhance the antileukemic effect and the adherence of CML progenitors to preformed stroma.
Bellucci R; Sala R; De Propris MS; Cordone I; de Fabritiis P
Leuk Lymphoma; 1999 Nov; 35(5-6):471-81. PubMed ID: 10609784
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR/ABL positive clone?
Verfaillie CM; Hurley R; Zhao RC; Prosper F; Delforge M; Bhatia R
J Lab Clin Med; 1997 Jun; 129(6):584-91. PubMed ID: 9178724
[TBL] [Abstract][Full Text] [Related]
16. The effect of interferon-alpha on beta-1 integrin mediated adhesion and growth regulation in chronic myelogenous leukemia.
Bhatia R; Verfaillie CM
Leuk Lymphoma; 1998 Jan; 28(3-4):241-54. PubMed ID: 9517496
[TBL] [Abstract][Full Text] [Related]
17. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation.
Damiano JS; Hazlehurst LA; Dalton WS
Leukemia; 2001 Aug; 15(8):1232-9. PubMed ID: 11480565
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.
Bhatia R; Wayner EA; McGlave PB; Verfaillie CM
J Clin Invest; 1994 Jul; 94(1):384-91. PubMed ID: 7518835
[TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
